Inteliview
Log inSign up
IPO Tracker
NuvOx Therapeutics, Inc.

NuvOx Therapeutics, Inc.

NuvOx Therapeutics, Inc.

USPricing
Valuation$26M
Original Target2026-07-17 (Date under review)
Sector--
Exchange--
RELATED IPOS
FreeCast, Inc.
FreeCast, Inc.FreeCast, Inc.US · --
GridAI Technologies Corp.
GridAI Technologies Corp.GridAI Technologies Corp.US · --
APEX Global Solutions Ltd
APEX Global Solutions LtdAPEX Global Solutions LtdUS · --
HCW Biologics Inc.
HCW Biologics Inc.HCW Biologics Inc.US · --
RanMarine Technology B.V.
RanMarine Technology B.V.RanMarine Technology B.V.US · --
Creatd, Inc.
Creatd, Inc.Creatd, Inc.US · --
FAQ

When is the NuvOx Therapeutics, Inc. IPO expected?

The NuvOx Therapeutics, Inc. IPO is currently in the Pricing stage. The originally expected date was 2026-07-17 and the process is ongoing. Timelines may change based on market conditions.

What is NuvOx Therapeutics, Inc.'s valuation?

NuvOx Therapeutics, Inc.'s estimated valuation is approximately $26M. The final valuation will depend on IPO pricing and market demand.

Can retail investors participate in the NuvOx Therapeutics, Inc. IPO?

U.S. IPOs are typically allocated to institutional investors first. Retail investors can purchase shares on NYSE/NASDAQ after listing. Some brokerages offer IPO access programs for pre-IPO allocation.